Eledon Pharmaceuticals Inc (ELDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 105,256 | 105,464 | 21,150 | 0 | N/A |
| TOTAL | $107,511 | $106,724 | $21,739 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 33 | 38 | 36 | N/A | N/A |
| Other Non-Current Assets | 200 | 221 | 1,645 | 0 | 0 |
| TOTAL | $233 | $259 | $1,681 | $N/A | $N/A |
| Total Assets | $107,744 | $106,983 | $23,420 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 765 | 2,889 | 1,216 | 0 | 0 |
| Accrued Expenses | 3,478 | 2,483 | 2,472 | 0 | N/A |
| TOTAL | $4,243 | $5,372 | $3,688 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 85,345 | 0 | 0 |
| TOTAL | $N/A | $N/A | $85,345 | $N/A | $N/A |
| Total Liabilities | $4,243 | $5,372 | $89,033 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 138 | 138 | N/A | N/A | N/A |
| Common Shares | 22 | 22 | 1 | 0 | N/A |
| Retained earnings | -86,351 | -80,143 | -73,753 | 0 | N/A |
| TOTAL | $103,501 | $101,611 | $-65,613 | $0 | $N/A |
| Total Liabilities And Equity | $107,744 | $106,983 | $23,420 | $0 | $0 |